🔗 Share this article

Given that the US undertakes unprecedented revisions to its vaccine schedules, an unexpected name has surfaced in a surprising turn: Høeg, a US-based sports medicine doctor and epidemiologist who rose to prominence by expressing skepticism about Covid shots in the pandemic and has focused upon potential deaths after Covid immunization in her short tenure at the FDA.

Scheduled Shifts to Pediatric Immunization Program

Health officials planned to announce sweeping changes to the childhood immunization program earlier this month, aligning the US with the Danish immunization schedule, according to reports – a significant shift that would place the US out of alignment with many the international standard with little proof for public health gain. The announcement has been pushed back until the coming year.

Rather than the top vaccines chief, Høeg is set to speak at the gathering. She was recently named temporary leader of the FDA’s CDER, the fifth individual to run the division this calendar year.

A Shift at the Regulatory Body

Høeg's temporary position could signify a strengthened alliance between the drug and biologics centers as Høeg and Prasad strengthen their influence at the agency – and it points to a greater focus upon dismantling already-approved immunizations at the FDA.

Dr. Høeg has often pushed for ending specific pediatric shot schedules in the US so as to align more like Denmark, a society with nationalized medicine and a number of inhabitants approximately the population of Wisconsin’s.

In her initial statements, she has continued to focus on vaccines – typically the purview of Dr. Prasad, chief of the FDA’s Center for Biologics Evaluation and Research (CBER) – rather than drug regulation.

Questions Over Background

Høeg has no apparent experience in drug development, approval processes or administrative roles, which has been standard for former directors of the CBER. She has worked at the FDA as a top consultant to the commissioner and CBER since March.

“She doesn’t seem to have the necessary background” for running the drug-regulation department, remarked Dr. Jonathan Howard. “She’s never run a clinical trial. She is not versed in managing a sizeable institution. She has no expertise in industry regulation.”

Previous heads of CBER would “grasp laws and regulations and the underlying principles of medication creation”, noted Janet Woodcock. “Objectively, she lacks the sort of resume that former directors who headed the center have had.”

The drug center has an enormous range of responsibilities at the agency, the former commissioner emphasized.

“Everybody just pays attention on the innovative therapies, but the generic program authorizes a multitude of off-brand pharmaceuticals. There is also a biosimilars program, over-the-counter program and so forth, and each of these must be looked after,” Woodcock noted. “The responsibility you overlook, that is precisely what that I always told people is going to bite you.”

Additionally, a major management component to the job, which supervises more than 5,000 staff members. “It is a huge leadership role, if you perform it correctly,” she concluded.

Agency Reaction and Disputed Policies

When asked about questions about Dr. Høeg's fitness for the role and whether this appointment represents greater collaboration among agency officials on vaccines, a spokesperson responded that the “inquiries are based on inaccurate premises”.

“Her experience is consistent with the responsibilities of her position,” the official stated, citing the time Høeg spent advising the FDA commissioner on “pharmaceutical safety and regulatory science, including computerized risk analysis and vaccine surveillance”.

As the temporary head, Høeg assumes responsibility for the agency head's new expedited review system, a controversial expedited medication authorization process that apparently concerned her preceding directors. “By what process are these medications being picked for this voucher program? Who makes the choices?” Howard said. “There is a lot of confidentiality going on at the agency right now.”

Broadly speaking, he remarked, “the Food and Drug Administration appears to be shifting towards more relaxed regulations of all drugs, except for vaccines.”

Public Past Work on Immunizations

With immunizations, Høeg has a clearer, if troubling, history, critics have noted. She released a research paper using non-validated volunteer-provided data to determine the frequency of heart inflammation after Covid vaccination. She consulted for the Florida chief medical officer Dr. Joseph Ladapo, who reportedly have altered data to suggest Covid vaccinations are pose a greater threat than they are.

Among her “wish list” for the current government encompassed altering rules for recently developed shots and discontinuing “non-essential” immunizations, she stated following the vote on a online show. At the FDA, Dr. Høeg has allegedly proposed preventing teenage boys from getting COVID-19 vaccines.

“She’s an thorough ideologue who commences with her beliefs and reverse-engineers to retrofit the evidence in a highly disingenuous, fraudulent way,” Dr. Howard stated.

Consolidating Power and a “Revenge Tour”

Dr. Høeg joined fellow dissenters, {like|